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The total number of circulating CD4+ and CD8+ T-cells undergoing clonal expansions following SIVmac251 infection was determined
using a T-cell receptor Vh chain (TRBV) third complementarity-determining region (CDR3) DNA heteroduplex tracking assay (HTA). This
assay measures the number of newly expanding T-cell clones but not their antigenic specificity. Fewer expanding CD4+ (3–23 per animal)
than CD8+ (18–37 per animal) clonotypes were observed during the acute phase of SIV infection. CD8+ T-cell expansions peaked at 4
weeks postinfection (wpi) concomitant with early reductions in viremia. Expanding clone TRBV transcripts ranged in frequency from the
limit of detection of 2% to 40% of their TRBV subfamily’s transcripts. The number of expanding CD4+ or CD8+ clones correlated with
neither peak, subsequent slope, nor steady-state viremia. CDR3 repertoires in CD8-expressing cells in different anatomical compartments
were also analyzed. Repertoires were polyclonal in the thymus, oligoclonal in mesenteric lymph nodes, peripheral blood mononuclear cells
(PBMC), and spleen, and extremely oligoclonal in intra-epithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL). The lack of
correlation between the number of expanding T-cell clonotypes and viremia levels may reflect the highly variable selection pressure imposed
on SIV by T-cell responses targeting different epitopes in outbred macaques.
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Clonal expansions of antigen-specific lymphocytes char-
acterize early immune responses. A central role for CD8+ T-
cell responses in controlling HIV and SIV infections is
suggested by the temporal link between reductions in
viremia during acute infection and initial anti-HIV cytotoxic
T-lymphocyte (CTL) responses in human, increasing SIV
viremia following CD8+ cell depletion in rhesus macaques,
and rapid selection of CTL viral escape mutants (Allen et
al., 2000; Borrow et al., 1997; Chen et al., 1995; Jin et al.,
1999; Koup et al., 1994; Ogg et al., 1998; Schmitz et al.,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.01.022
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E-mail address: delwarte@medicine.ucsf.edu (E.L. Delwart).1999). Maintenance of HIV-specific CD4+ responses also
appears important in controlling viremia (Douek et al.,
2002b; Rosenberg et al., 1997). Measurements of T-cell
expansions in HIV or SIV infection have revealed the
generally oligoclonal nature of CD8+ cell responses (Chen
et al., 1995, 2001; Pantaleo et al., 1994, 1997b; Wilson et
al., 1998) and both transient and long-lived T-cell clones
have been observed (Chen et al., 2001; Islam et al., 2001;
Kalams et al., 1994; Pantaleo et al., 1997b; Soudeyns et al.,
2000). A study of CD8+ cell response indicated that a more
diverse response, measured as changes in the relative
representation of mRNA from a greater number of T-cell
receptor Vh chain (TRBV) subfamilies, was associated with
lower subsequent viremia (Pantaleo et al., 1997a).
Measuring changes in T-cell repertoire following HIV
infection by analyzing cell surface expression of different
TRBV subfamilies, or changes in the relative frequency of
different TRBV subfamily mRNA transcripts, is made
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samples and of frequent postinfection bleeds. Because the T-
cell repertoire, particularly of CD8+ cells, shows the pres-
ence of expanded T-cell clones even in healthy HIV-nega-
tive adults (Bernardin et al., 2003; Hingorani et al., 1993;
Posnett et al., 1994), baseline samples are necessary to
differentiate novel from preexisting T-cell expansions.
Measurements of HIV-specific T-cell responses are also
limited to previously defined epitopes, identified using
protein expression systems of historically important HIV
reference strains, or peptide libraries derived from HIV
subtype B consensus genome, rather than the autologous
strain actually inducing the cellular response. The recent use
of rhesus macaques inoculated with the molecularly cloned
pathogenic virus SIVmac239 has allowed the total CD8+
response to be measured to the actual infecting strain
(Mothe et al., 2002). The number of T-cell clonotypes
(distinct CDR3) recognizing any single epitope in HIV or
SIV infection has been shown to range from monoclonal to
as high as 15 CDR3 clonotypes (Chen et al., 2001; Cohen et
al., 2002; Douek et al., 2002a; Kalams et al., 1994; Wilson
et al., 1998).
The total number of T-cell clonotypes expanding follow-
ing HIV or SIV infection remains poorly defined. The
greater the number of distinct CD8+ T-cell clones recogniz-
ing a given epitope, the harder it may be for the virus to
escape recognition through mutations abrogating T-cell
recognition. The clonotypic composition of the cellular
immune response may therefore be an important component
of the interaction between responding T-cell populations and
rapidly evolving viral quasispecies.
We recently adapted a DNA heteroduplex tracking assay
(HTA), originally developed for the analysis of genetically
complex viral populations (Delwart et al., 1993, 1998;
Sullivan et al., 1998), to the study of the TRBV CDR3
repertoire (Bernardin et al., 2003; Shen et al., 1998). By
simplifying the gel pattern derived by traditional TRBV
DNA heteroduplex analysis such that every distinct band
now reflects the presence of a unique CDR3 sequence, we
were able to directly enumerate the number of expanding T-
cell clones. TCR-HTA is able to detect smaller clonal
expansions than is possible with the CDR3 length spectra-
type method, which requires a disruption in the Gaussian
distribution of an 8 to 9 band pattern (Pannetier et al., 1993;
Shen et al., 1998). Quantification of the TCR-HTA band
intensity also allows the representation of a given CDR3
sequence variant to be measured as a percentage of its
TRBV subfamily’s transcripts. Distinct TCR-HTA bands
reflect clonal T-cell expansions as shown by their predom-
inance in activated/memory CD4+ and CD8+ cells (CD3+
CD45RO+ CD62L), and their absence from naive CD4+
and CD8+ cells (CD3+ CD45RA+ CD62L+) and CD8+
cells from newborn human cord blood (Bernardin et al.,
2003; Shen et al., 1998).
We applied this new method to a longitudinal analysis of
the CD4+ and CD8+ TRBV repertoire in peripheral bloodduring primary SIVmac251 infection of rhesus macaques. The
total number of T-cell expansions occurring concomitantly
with the initial control of viremia was measured and
evaluated in relation to viral suppression.Results
Primary SIVmac251 infection of rhesus macaques
Viral loads, percentage of CD4+ and CD8+ cells, and
CD4+/CD8+ ratio in longitudinal samples of peripheral
blood were measured following intravenous inoculation of
six rhesus macaques with 100 TCID50 of SIVmac251 (Fig. 1).
For five of six monkeys, the peak of viremia was observed
at 2 weeks postinfection (wpi). For macaque 30565, the
viral load peaked at 4 wpi at a value lower than the other
animals but did not fall substantially thereafter remaining at
approximately 106 copies/ml. In macaque 30205, viremia
also barely declined remaining at 5  107–108 copies/ml. A
partial (30246, 30651) or more efficient (30803, 30817)
control of viremia was observed in the other animals,
reducing the peak viral load by 2–3 log. At 9 wpi, all
animals were treated daily with 9-[2-(Phosphonometoxy)-
propyl]adenine (PMPA) antiviral monotherapy.
Flow cytometric analysis showed a generalized loss in
the CD3+CD4+ T cell counts during the time of peak
viremia followed by a rebound. The percentage of
CD3+CD8+ cells generally showed a sharp and transient
increase at 2–5 wpi. A strong drop in the CD4/CD8 ratio
was observed starting at 2 wpi (Fig. 1).
Clonotypic expansions in circulating CD4+ and CD8+
lymphocytes detected by TCR-HTA
To characterize TRBV repertoire changes underlying
these T-cell population fluctuations, we collected peripheral
blood mononuclear cells (PBMC) from all macaques at 2
weeks before infection and 2, 3, 4, and 5 weeks postinfec-
tion. Total RNA was purified from CD4+ and CD8+ T
lymphocyte populations positively selected using immuno-
magnetic beads and the CDR3 regions of all 24 TRBV
subfamilies were amplified by RT-nPCR (Materials and
methods) (Bernardin et al., 2003). Each PCR amplicon
was re-annealed with a clonal Cy5-labeled probe belonging
to the same TRBV subfamily and DNA heteroduplexes
were resolved on 5% polyacrylamide gels (Bernardin et
al., 2003). The Cy5-labeled heteroduplexes were then
revealed by excitation with red laser light to yield TCR-
HTA band patterns (Materials and methods). A schematic
description of TCR-HTA methodology is shown in Fig. 2.
Distinct TCR-HTA patterns were observed in different
TRBV subfamilies (Fig. 3). A smear pattern without distinct
heteroduplex bands reflected a polyclonal TRBV subfamily
without prominent T-cell expansions (Fig. 3C). TCR-HTA
patterns with distinct DNA heteroduplex bands reflected
Fig. 1. SIVmac251 infection of rhesus macaques. Animals were inoculated
with SIVmac251 at week 0. Plasma viral RNA, CD4+ and CD8+
percentages, and CD4/CD8 ratio were determined as described in Materials
and methods. The shaded area represents the period animals were under
PMPA therapy.
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ed T-cell clones (Figs. 3A, B, E–G). Prior studies where
bands were extracted and sequenced have shown that
different TCR-HTA bands represent single expanded
CDR3 sequences (Bernardin et al., 2003). Longitudinally
analyzed CD8+ and CD4+ TRBV subfamilies exhibited
either stable (Figs. 3A and B) or changing (Figs. 3E–G)
oligoclonal patterns with the emergence or disappearance of
one or more heteroduplex bands. The TCR-HTA band
patterns from postinfection CD4+ and CD8+ cells were
compared to those of the same cell type and TRBV
subfamily collected before infection to detect novel TCR-
HTA bands reflecting emerging T-cell clonotypes with
distinct CDR3 sequences. Only the TCR-HTA bands emerg-
ing after infection (not those present at baseline) were
therefore measured in this study.
An important control for TCR-HTA (or any complex
population study) consisted of ensuring correct population
sampling. Correct sampling was ensured by only taking into
account TCR-HTA gel patterns that could be reproducibly
generated using independently generated PCR amplicons
(Figs. 3A–C, E–G). Two separate nPCR products from
each time point were therefore analyzed in neighboring
lanes of the same gel throughout this study (Fig. 3).
Reproducible sampling of the complex CDR3 sequence
mixtures was necessary as the appearance of oligoclonality,
and therefore of artifactual T-cell expansions, was generated
when insufficient levels of cDNA were used to generate
nPCRs (see examples in Figs. 3D and H). Each TRBV
subfamily (n = 24) from each time point (n = 5) from CD4+
and CD8+ T cells (n = 2) from each monkey (n = 6) was
therefore generated in duplicate from separate cDNA ali-
quots (n = 2). The minimum number of PCR amplifications
required for this TRBV repertoire analysis was therefore
2880 nested PCRs. When nonidentical TCR-HTA patterns
were generated in duplicate nPCRs (Figs. 3D and H), the
amplifications were repeated using twice the volume of
input cDNA. The nPCRs were then again compared by
TCR-HTA to ensure reproducible sampling. The final num-
ber of nPCRs generated and analyzed by TCR-HTA was
approximately 4000. Demonstrably reproducible TCR-HTA
patterns could be generated from a total of 78% of all TRBV
at all time points.
When the reproducibly generated TCR-HTA bands
emerging postinfection were counted, fewer clonal expan-
sions at any single time point were seen in the CD4+ than
in the CD8+ fractions (1–20 new CD4+ clonotypes versus
7–30 new CD8+ clonotypes, average: 5.7 CD4+ versus
14.3 CD8+ expansions per time point/animal). When all the
new T-cell expansions detected during the first 5 weeks
postinfection were counted, between 3–23 CD4+ and 18–
37 CD8+ expansions were detected per monkey. Clono-
typic expansions were distributed between 3–9 and 7–20
TRBV subfamilies for CD4+ and CD8+ cells, respectively.
Thus, more clonotypes in a larger number of TRBV
subfamilies were mobilized in CD8+ than in CD4+ cells
Fig. 2. Schematic description of the TCR-HTA assay. Ho: homoduplexes, He: heteroduplexes, ss: single-stranded DNA.
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transient (Figs. 3E and G) or persisted until the last time
point analyzed at 5 wpi (Figs. 3E and F). We alsoFig. 3. Representative examples of clonotypic expansions and other TCR-HTA p
oligoclonal and polyclonal TRBV subfamilies are shown in A, B, and C gels. Eme
G. Examples of nonreproducible CDR3 variant sampling are shown in gels D and
above horizontal bars. Time points analyzed are indicated relative to week of infec
to water to highlight the position of the Cy5-labeled single-stranded probe.frequently observed the decline of preexisting expanded
CDR3 clones present at baseline in the same TRBV
subfamily (Figs. 3F and G).atterns detected in CD4+ and CD8+ cells during primary infection. Static
rging clonotypes in dynamic TRBV subfamilies are shown in gels E, F, and
H. The two independently generated PCRs from each time point are shown
tion. H2O represents lanes where the TCR-HTA probe was re-annealed only
Fig. 4. CD4+ CD8+ T-cell clonotypic expansions postinfection. The frequency of each clonotype expanding postinfection is expressed as a percentage of its
TRBV subfamily’s transcripts. Each TRBV subfamily is represented with a different color. * Denotes expansions that reached 40% at 5 wpi, while ** denotes
31.3% at 4 wpi.
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analysis
The percentage of a TRBV subfamily specific amplicon
encoding a specific clonotype was estimated by TCR-HTA
fluorescence scanning. Prior reconstitution experiments
showed that heteroduplex band intensity reflected the frac-
tion of the PCR product consisting of a given CDR3 variant
at frequencies above 2% (Bernardin et al., 2003). Fluores-
cent band quantification therefore allowed the determination
of the frequency of emerging clonotypes within each TRBV
subfamily. To obtain a global view of TRBV repertoire
changes, we plotted the intra-TRBV subfamily frequencies
of all T-cell expansions emerging after infection (Fig. 4).
Different CD8+ and CD4+ T clonotypes peaked in frequen-cy throughout the postinfection period (Fig. 4). When the
total number of new expansions seen at any given time point
postinfection was plotted, the greatest average number of
expansions was detected at 4 wpi for CD8+ and 5 wpi for
CD4+ cell clonotypes (Fig. 5).
Because the percentage of cells expressing each of the 24
different TRBV was not known, the assumption was made
that equal number of cells expressed each of the 24 different
TRBV. The frequency of expanding T-cell clones as a
percentage of all CD4+ or CD8+ cells was then approxi-
mated by dividing their intra-TRBV subfamily frequencies
by the number of TRBV subfamilies (i.e., divided by 24).
The total frequency of expanding T-cell clones was then
calculated by adding up all the resulting estimated clonotype
frequencies. The total clonotype frequency peaked in the
Fig. 5. Total numbers of TRBV expansions at different times postinfection in CD4+ and CD8+ cells. The black bars represent the average values for the six
animals at each time point.
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not shown).
The number or estimated total frequency of clonal
expansions is not correlated with control of viremia
A correlation between the total number or estimated total
frequency of expanding CD4+ or CD8+ clonotypes and
either the peak viremia levels, the subsequent slope of
viremia, or the following steady state viremia levels was
tested (Table 1). No statistically significant correlation was
detected. Animal 30803, showing the best control of vire-
mia, had the highest number of CD8+ expansions (n = 37),
but animal 30817, with the next best control of viremia, had
the lowest number of CD8+ expansions (n = 18). The
greatest (n = 23) and lowest (n = 3) numbers of CD4
expansions were detected in animals 30651 and 30565,
respectively, who both displayed weak control of theirTable 1
The number or estimated frequency of clonal expansions is not correlated
with control of viremia
New expansions Linear regression analysisa
Peak VLb;
R ( P)
Slope VLc;
R ( P)
Steady stated;
R ( P)
Total number CD4+ 0.234 (0.655) 0.022 (0.966) 0.060 (0.910)
CD8+ 0.131 (0.805) 0.297 (0.568) 0.370 (0.471)
CD4+
and CD8+
0.052 (0.922) 0.192 (0.716) 0.219 (0.676)
Estimated CD4+ 0.391 (0.444) 0.351 (0.495) 0.263 (0.615)
frequency CD8+ 0.476 (0.340) 0.160 (0.763) 0.268 (0.608)
CD4+
and CD8+
0.159 (0.763) 0.409 (0.421) 0.446 (0.376)
a R and two-tailed P values are shown.
b VL: log10 of the viral load in SIV RNA copies/ml of plasma was used.
c Slope of the viral load between 2 and 9 wpi (animal 30565, between 4 and
9 wpi).
d Average of the viral load between 9 and 17 wpi.viremia. Furthermore, no statistical correlation was seen
between the number of CD4+ and the number of CD8+
clonal expansions (Spearman–Rank test, P = 0.370) nor
between the cumulative frequency of CD4+ and that of
CD8+ clonal expansions (Spearman–Rank test, P = 0.276).
TCR TRBV repertoire analysis in different anatomical sites
All six infected macaques were treated with PMPA
monotherapy starting at 9 wpi, resulting in variable sup-
pression of viremia (Fig. 1) and the rapid emergence of
PMPA drug-resistant mutations (Magierowska et al.,
2004). Animal 30565 was sacrificed at 17 wpi, 30246 at
20 wpi, 30817 at 29 wpi, 30205 at 38 wpi, 30651 at 57
wpi, and 30803 at 64 wpi. PBMC, mesenteric lymph
nodes (MesLN), thymus, spleen, intra-epithelial lympho-
cytes (IEL), and lamina propria lymphocytes (LPL) were
then collected during necropsy. Tissue CD8+ cells from an
uninfected juvenile macaque were also analyzed. Eight
TRBV subfamilies were analyzed (TRBV 4, 11, 13, 19,
20, 23, 24, and 28). Representative TCR-HTA results are
shown in Fig. 6. Again, only reproducible TCR-HTA
patterns were taken into account to ensure representative
CDR3 population sampling.
Highly variable levels of TCR TRBV oligoclonality
were observed in CD8+-expressing cells from different
tissues. CD8+-expressing cells in the thymus consistently
displayed a polyclonal TRBV repertoire (no distinct bands
in the TCR-HTA) as expected due to the overwhelming
presence in that tissue of unselected CD4+CD8+-double
positive thymocytes. CD8+ cell expansions were detected
in both MesLN and PBMC, with most—but not all—of the
clonotypes (TCR-HTA bands) overlapping between the two
tissues. Spleen CD8+ cells generally appeared more oligo-
clonal than MesLN or PBMC, again with some clonotype
overlap. CD8+ cells from IEL and LPL were highly
oligoclonal, with nearly identical clonotype composition
that showed no overlap with clonotypes from the other
Fig. 6. Variable levels of oligoclonality in different lymphoid tissues. (A) CD8+-expressing cells were purified from diverse lymphoid tissues (thymus,
mesenteric lymph node [MesLN], PBMC, spleen, intraepithelial lymphocytes [IEL], and lamina propria lymphocytes [LPL]) and used for TCR-HTA. The two
independently generated PCRs from each time point are shown above horizontal bars. Representative TCR-HTA gels are shown. (B) The entropy of the TCR-
HTA fluorescent signal distribution was determined for all TRBV subfamilies from all animals for which a reproducible TCR-HTA could be generated and is
plotted here together with the average entropy and its standard deviation.
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fected macaque CD8+ cells were similar to those in
infected animals including highly oligoclonal IEL and
LPL (Fig. 6A, 30327). The level of oligoclonality seen inTCR-HTA gels was quantified by measuring the entropy of
the fluorescent signal distribution. A high entropy value
indicated the presence of a polyclonal T-cell population
while a lower value reflected the presence of expanded T-
F. Bernardin et al. / Virology 322 (2004) 105–117112cell clones. The distribution of entropy values seen within
the same tissue reflected differences in the level of oligo-
clonality in different TCR TRBV subfamilies in different
animals. Quantification of the TCR-HTA signal confirmed
the visual analysis of the gels, with thymic CD8+ cells
exhibiting high TCR-HTA entropy, while intestinal intra-
epithelium CD8+ cells displayed a lower TCR-HTA entro-
py reflecting a highly oligoclonal repertoire (Fig. 6B).Discussion
DNA heteroduplex tracking assays for the high-resolu-
tion analysis of TRBV CDR3 populations were used to
detect T-cell expansions in the peripheral blood during the
acute phase of SIV infection. Unlike antigen-specific meas-
urements of immune responses, the TCR-HTA used here
measured global changes in the T-cell repertoire without
restrictions due by the choice of the particular in vitro assay
or the number or strain of the antigenic peptides used.
Although the specificity of the T-cell expansions measured
here are unknown, their emergence coincided with initial
control of viremia and was suggestive of a primary immune
response to SIV. Because some of the expanding clonotypes
may include non-SIV specific cells, they therefore represent,
within the limits of detection of TCR-HTA, an upper limit of
the number of early expanding SIV-specific clonotypes.
Multiple T-cell expansions were found in each animal.
Three to 23 CD4+ and 18–37 CD8+ expanding clonotypes
were detected per animal. The number of CD8+ expansions
seen here is consistent with the 2–12 peptide pools
inducing gamma IFN secretion seen when the entire
infecting SIVmac239 amino acid sequence was tested for
CD8+ activation (Mothe et al., 2002) and the 1–15 CD8+
CDR3 clonotypes estimated to target each antigenic peptide
(Chen et al., 2001; Cohen et al., 2002; Douek et al., 2002a;
Kalams et al., 1994; Wilson et al., 1998). CD8+ clonotype
frequency was also highly dynamic with large fluctuations
during the first 5 weeks of infection. Rapid changes in SIV-
specific clonotype frequency have also been observed in
the number of cells staining with MHC class I tetramers
loaded with gag peptide (Chen et al., 2001).
Fewer CD4+ than CD8+ clonal expansions were
detected. CD4+ cell expansions were also largely tran-
sient. Because viral-specific CD4+ cells are expected to be
preferentially infected, the expanding CD4+ clonotypes
may have been eliminated by direct viral cytotoxic effects
(Douek et al., 2002b). HIV-specific CTL activity, as well
as activation-induced cell death (Van Parijs and Abbas,
1998), may also account for the rapid contraction of most
CD4+ clones soon after infection. The absence or low
levels of HIV p24-specific CD4+ cell proliferative re-
sponse in chronically infected subjects also indicate that a
reduced number of HIV-specific CD4+ cells remain active
past the acute stage of infection (Rosenberg et al., 1997,
1999). The loss of CD4+ clonotypes we observed veryearly in primary infection may also have had the conse-
quence of decreasing signals necessary for an effective
CD8+ cell memory response (Shedlock and Shen, 2003;
Sun and Bevan, 2003).
Our TCR-HTA strategy for the study of T-cell repertoire
changes offers some advantages over semiquantitative PCR
(Chen et al., 1993, 1995; Labrecque et al., 1993; Pantaleo et
al., 1994) and CDR3 length analysis (Chen et al., 2001;
Gorochov et al., 1998; Pannetier et al., 1993; Wilson et al.,
1998; Zhou et al., 1999). Similar to semiquantitative PCR
analyses using TRBV subfamily specific primers, TCR-
HTA provides a measure of fluctuations in the transcripts
of each subfamily, rather than the absolute frequency of
transcripts from each subfamily. Unlike semiquantitative
PCR, TCR-HTA provides a simple means to visualize the
distribution of CDR3 variants within each TRBV subfamily.
The ability of TCR-HTA to visualize overrepresented CDR3
sequence variants allowed us to quantify the number of
expanding T-cell clones within each TRBV subfamily.
CDR3 length analysis, because of its lower sensitivity to
minor T-cell expansions than TCR-HTA (Shen et al., 1998)
and its inability to detect different CDR3 sequence of the
same length, may not have detected many of the minor T-
cell expansions we observed (Fig. 4). Ensuring correct and
representative sampling of the CDR3 variant population, as
was done in this study by analyzing in parallel duplicate
PCR products, also increased the confidence that the
detected expansions were not sampling artifacts of low cell
numbers or inefficient RT-PCR.
CD8+ cells presented different levels of oligoclonality in
different tissues. Extreme oligoclonality was found in CD8+
cells from gut tissues. Similarly restricted CD8+ cell TCR
repertoire in the gut tissue of an uninfected macaque indi-
cated that this phenomenon was not a consequence of SIV
infection. Highly restricted TCR repertoires of IEL have
been reported in mouse and human (Balk et al., 1991;
Blumberg et al., 1993; Regnault et al., 1995, 1996; Van
Kerckhove et al., 1992). The distribution of identical CD8+
cell clonotypes in IEL and LPL has also been noted in mice
(Arstila et al., 2000). The separate developmental path taken
by IEL and LPL relative to PBMC CD8+ cells may account
for their strikingly reduced repertoire diversity. IEL may be
derived from an expansion of a relatively smaller number of
T cell clones and may be effective against a limited number
of antigens. The generally more restricted CD8+ cell reper-
toires seen in the spleen relative to PBMC and lymph nodes
are also consistent with the particularly high levels of virus-
specific CD8+ cells in this tissue (Cheynier et al., 1994;
Hosmalin et al., 2001; Kuroda et al., 2000).
CD8+ response measured using HLA tetramer staining to
a limited number of epitopes or using in vitro cytolytic
activity has shown a negative correlation between virus-
specific CD8+ cell responses and viremia levels (Betts et al.,
1999; Connick et al., 2001; Greenough et al., 1997, 1999;
Legrand et al., 1997; Musey et al., 1997; Ogg et al., 1998;
Pontesilli et al., 1998). Unexpectedly, the inverse correlation
F. Bernardin et al. / Virology 322 (2004) 105–117 113was seen when measuring CD8+ IFN-gamma production in
response to peptides covering the entire HIV consensus
genome (Betts et al., 2001) or selected epitopes (Buseyne et
al., 2002). We found no statistically significant correlation
between the total number or estimated frequency of CD4+
or CD8+ clonotypes and either the peak, slope, or steady-
state viremia. Because our studies did not identify which of
the observed T-cell expansions were SIV specific, it is
nonetheless possible that a correlation between the number
or frequency of SIV-specific clonotypes and control of
viremia exists. The lack of correlation we observed using
TCR-HTA may reflect the complexity of the host–virus
interaction, where not only the efficiency of the T-cell
responses but also the replicative fitness of the infecting
viral strain likely influences the level of viremia. The
outbred macaques infected here with the same SIV inocu-
lum are expected to have targeted distinct viral epitopes due
to their different MHC background. The frequency of the
appropriate CTL escape mutants in the viral quasispecies of
different macaques and the replicative fitness of such viral
mutants are likely to differ widely and may account for the
lack of a simple correlation between T-cell clonotype
numbers and viremia measured in this study.Materials and methods
Animals, virus, and inoculation
Six juvenile male rhesus macaques (2–3 years old) from
the type D-retrovirus-free colony at the UC Davis California
National Primate Research Center (CNPRC) were inoculat-
ed intravenously under ketamine anesthesia (10 mg/kg of
body weight intramuscularly) with 100 TCID50 of a well-
characterized SIVmac251 isolate, SIVmac251-5/98 (Greenier et
al., 2001). This virus stock, propagated on rhesus PBMC,
had a titer of 105 TCID50 and 1.4  109 copies RNA/ml
measured by SIV bDNA and has been demonstrated to be
pathogenic in adult rhesus macaques (Greenier et al., 2001).
Animals were moved to a biosafety level 3 facility 1 week
before SIV inoculation and kept there until necropsy.
Animals were treated in accordance with American Asso-
ciation for Accreditation of Laboratory Animal Care stand-
ards. We strictly adhered to the Guide for the Care and Use
of Laboratory Animals prepared by the Committee on Care
and Use of Laboratory Animals of the Institute of Labora-
tory Resources, National Resource Council. At week 9
postinfection, all animals were treated with one daily
subcutaneous 30 mg/kg injection of 9-[2-(Phosphonometox-
y)propyl]adenine (PMPA or tenofovir) (Gilead Sciences,
Foster City, CA) (Magierowska et al., 2004). PMPA was
prepared as described (Van Rompay et al., 1999). Animals
were sacrificed at 17–64 weeks postinfection (wpi) with an
intravenous overdose of pentobarbital (60 mg/kg). To re-
duce organ contamination with blood, several liters of 0.9%
NaCl were infused into the left ventricle or ascending aortauntil totally clear fluid exited the severed right atrium. A
complete necropsy examination was performed and a rou-
tine histopathologic examination was done on collected
tissues.
Plasma viral load
SIVmac251 RNA was quantified in duplicate using a real-
time RT-PCR assay as previously described (Amara et al.,
2001). RNA copy number was determined by comparison
with an external standard curve consisting of in vitro tran-
scripts representing bases 211–2101 of the SIVmac239 ge-
nome. The assay has a sensitivity of V160 RNA copies/ml
of plasma and a linear dynamic range from 102 to 108
copies/ml (R2 = 0.99).
T-lymphocyte phenotyping
T-lymphocyte subsets were detected as described previ-
ously (Van Rompay et al., 2000). Briefly, direct labeling of
whole blood used PerCP-conjugated antihuman CD8 (Leu-
2a; Becton Dickinson Immunocytometry Inc., San Jose, CA),
phycoerythrin-conjugated antihuman CD4 (OKT4; Ortho
Diagnostic Systems Inc., Raritan, NJ), and fluorescein-con-
jugated antihuman CD3 (Pharmingen, from Becton Dick-
inson). Red blood cells were lysed and the samples were fixed
in paraformaldehyde by using the Coulter Q-prep system
(Coulter Corp., Hialeah, FL). Lymphocytes were gated by
forward and side light scatter and were then analyzed with a
FACScan flow cytometer (Becton Dickinson).
Cell preparation and immunomagnetic cell purification
PBMCs were isolated from EDTA anti-coagulated
blood samples by centrifugation over Ficoll-Hypaque
(Amersham Pharmacia Biotech, AB, Uppsala, Sweden) at
2000 rpm for 40 min in a Beckman Acuspin centrifuge at
room temperature. Plasma was then aliquoted and frozen at
80 jC. Cells were rinsed twice (2000 rpm, 10 min) in
Ca2+- and Mg2+-free PBS. Spleen cell suspensions were
homogenized by passing through a 70-Am mesh size cell
strainer (Falcon), centrifuged over Ficoll-Hypaque, and
washed using the same procedure as for blood cells.
Thymus and lymph node cell suspensions were collected
by macroscopically disrupting the tissue architecture using
a scalpel and were washed twice in Ca2+- and Mg2+-free
PBS. IEL and LPL were isolated from jejunum samples
according to previously described procedures (Mattapallil
et al., 1998; Smit-McBride et al., 1998). Cells (107) from
each tissue were resuspended in PBS without Ca2+ and
Mg2+, supplemented with 0.5% BSA and 2 mM EDTA.
Positive selection for CD8+ cells was carried out by
incubating the cells with anti-CD8 (IgG1, Leu 2a, SK1)
immunomagnetic beads (Myltenyi Biotech, Auburn, CA)
for 15 min at 6 jC. Cells were then applied onto MS+
separation columns attached to a magnetic separator (Myl-
F. Bernardin et al. / Virology 322 (2004) 105–117114tenyi Biotech). The columns were rinsed with the separa-
tion buffer and CD8+ cells were collected. A second
positive selection for CD4+ cells was then realized on the
flow through CD8- fraction. After centrifugation for 2 min
at 2000 rpm, CD8- cells were resuspended in separation
buffer and incubated with anti-CD4 (IgG1, Leu 3a, SK3)
immunomagnetic beads (Myltenyi Biotech) and CD8-
CD4+ cells were purified as described for CD8+ cells.
Purity was expected to be approximately 95% according
to the manufacturer. The detection of distinct TCR-HTA
bands in CD4+ versus CD8+ purified cells attests to the
purification of different T-cell populations.
RNA purification and cDNA synthesis
Total cellular RNA from CD8+ and CD4+ T-cells was
purified using the RNeasy mini-kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions, followed by
the immediate addition of 20 U of RNAse inhibitor (RNA-
sin, Roche Diagnostic Corporation, Indianapolis, IN). First
strand cDNA synthesis used 1 Ag RNA, 1.5 Ag of 6
nucleotide long random primers (Gibco BRL Life technol-
ogies, Rockville, MD), and 200 U of murine leukemia virus
reverse transcriptase RNAse H (Gibco BRL Life technol-
ogies) at 37 jC for 50 min in a final volume of 20
Al according to manufacturer’s instructions.
Amplification of the CDR3 region by nested PCR
To amplify the CDR3 region of each TRBV subfamily,
nested PCR using primers specific to each of the 24 TRBV
subfamilies was performed on random-primed cDNA. An
input of 2.5 Al of cDNA was used for the amplification of
each TRBV subfamily. One reverse transcription (RT)
reaction was therefore enough for the PCR amplification
in duplicate of four TRBV subfamilies. The first PCR round
used a forward primer specific to one TRBV subfamily and
a reverse primer in the TRBC region common for all TRBV
subfamily transcripts. The second round PCR was initiated
with 2 Al of the first round and used an internal forward
primer specific for the same TRBV subfamily and an
internal constant region primer common for all TRBV
subfamily. All primers have been previously described
(Bernardin et al., 2003). When homologous TRBV sequen-
ces were available in GenBank for humans and macaques,
the primer binding sites were 98–100% similar. PCR
products ranged in size from 244 to 458 base pairs and
were all consistent with their expected size based on the
human TRBV sequence (Bernardin et al., 2003). Each PCR
used 10 pmol of each primer, 2.5 mM MgCl2, 200 AM
dNTP, in 1 buffer with 1 U Taq DNA polymerase
(Promega, Madison, WI), in a final volume of 30 Al. A
PCR express thermocycler (Hybaid, Franklin, CA) was used
as follows: 3 cycles of 94 jC for 1 min, 57 jC for 45 s, 72
jC for 1 min, followed by 32 cycles of 15 s at 94 jC, 15 s at
57 jC, 15 s at 72 jC, with a final extension of 5 min at 72jC. The TRBV nomenclature used is described in the
ImmunoGeneTics database (IMGT) website at http://
imgt.cines.fr (Lefranc, 2001). The IMGT nomenclature
was approved by the HUman Genome Organization
(HUGO) Nomenclature Committee (HGNC) in 1999. Cor-
respondence between the IMGT and other T-cell receptor
nomenclatures can be found at http://imgt.cines.fr/textes/
IMGTrepertoire/LocusGenes/nomenclatures/human/TRB/
TRBV/Hu_TRBVnom.html#4.
TCR-HTA and clonotype quantitation
TCR-HTA for all 24 TRBV subfamilies was performed
as previously described (Bernardin et al., 2003). Briefly,
Cy5-labeled clonal TCR-HTA probes for each of the 24
TRBV subfamilies were generated using the appropriate
second round variable region PCR primer and a Cy5-labeled
constant region primer (Bernardin et al., 2003). Ten nano-
grams of sequence-confirmed plasmid subclones of each of
the 24 TRBV subfamilies was used to initiate the probe
generating PCR (Bernardin et al., 2003). The TCR-HTA
probes were generated using human TRBV plasmid sub-
clones (Bernardin et al., 2003). The strong level of sequence
conservation in the constant and variable domains of mac-
aques and human TRBV (Bontrop et al., 1995; Jaeger et al.,
1993, 1994) was sufficient for TCR-HTA probes and target
DNA to hybridize. The target PCR DNA was generated
from cDNA derived from CD4+ or CD8+ cells by nPCR.
One microliter of Cy5-labeled TCR-HTA probe was then re-
annealed to 4 Al of RT-nPCR product belonging to the same
TRBV subfamily. The probe and target mixture were
denatured for 2 min at 95 jC using a thermocycler and
rapidly cooled on ice. DNA heteroduplexes formed between
the Cy5-labeled clonal probe and the complex mixtures of
CDR3 sequence variants from CD4+ or CD8+ cells were
then separated on 16 cm high, 1.5 mm thick, 5% polyacryl-
amide gels in 1 TBE at 210 V for 2 h. TCR-HTA gels
were scanned for red fluorescence with a Storm 860
(Molecular Dynamics, Sunnyvale, CA) and the results were
visualized and analyzed with the ImageQuant 5.1 program
(Molecular Dynamics). The ImageQuant program was used
to quantitate the signal intensity of distinct TCR-HTA
bands. The TCR-HTA band signal was then divided by
the total signal intensity emanating from all DNA hetero-
duplexes in the same gel lane to derive the percentage of the
CDR3 clonotype transcript within its TRBV subfamily. The
DNA homoduplex and single-strand fluorescent signals
originating, respectively, from self-reannealing and non-
annealing (single stand) of the Cy5-labeled probe were
excluded from the total DNA heteroduplex Cy5 signal.
The electrophoretic mobilities of DNA homoduplexes and
single-stranded DNA were determined by referring to the
gel lane where the probe alone was analyzed. The average
of the percentage representation of CDR3 clonotypes gen-
erated from the two independent duplicate nPCR products is
reported.
rology 322 (2004) 105–117 115Entropy of TCR-HTA signal
After fluorescent scanning of TCR-HTA gels using the
ImageQuant program, the signal intensity of DNA hetero-
duplexes along the gel lane length was measured at each
pixel position excluding regions of single-stranded probe
and DNA homoduplexes signals. The values were entered in
the HDent interface (http://hiv-web.lanl.gov/content/hiv.db/
HD-WEB/HDent.html) to calculate the Shannon entropy of
the signal distribution in 50 bin along the gel lane length.
Shannon entropy is a measure of signal distribution or
spread in each gel lane and is used here as a quantitative
measure of CDR3 sequence diversity (Delwart et al., 1997;
Dickover et al., 2001; Ping et al., 2000; Wang et al., 1998).
The entropy/maximum entropy values range from 0 to 1.
When the entire TCR-HTA gel signal is in a single bin, the
result is a minimum entropy of 0. When the TCR-HTA gel
signal is equally distributed in every bin, the result is a
maximum entropy value of 1.
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